Report on Global PARP

2023-2031 Report on Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Player, Region, Type, Application and Sales Channel

Report on Global PARP

2023-2031 Report on Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Player, Region, Type, Application and Sales Channel


Discover the latest insights into the booming PARP (Poly ADP Ribose Polymerase) Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

This report studies the PARP (Poly ADP-Ribose Polymerase) Inhibitor market, covering market size for segment by type (Lynparza, Zejula, etc.), by application (Ovarian Cancer, Breast Cancer, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AstraZeneca, Merck & Co, GSK, Clovis Oncology, Pfizer, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for PARP (Poly ADP-Ribose Polymerase) Inhibitor from 2017-2022, and provides extensive market forecasts from 2023-2031 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the PARP (Poly ADP-Ribose Polymerase) Inhibitor market.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of PARP (Poly ADP-Ribose Polymerase) Inhibitor including:

AstraZeneca

Merck & Co

GSK

Clovis Oncology

Pfizer

Zai Lab

Market split by Type, can be divided into:

Lynparza

Zejula

Rubraca

Talzenna

Market split by Application, can be divided into:

Ovarian Cancer

Breast Cancer

Other

Market split by Sales Channel, can be divided into:

Direct Channel

Distribution Channel

Market segment by Region/Country including:

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain etc.)

Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

South America (Brazil, Argentina and Colombia etc.)

Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Chapter 1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview

1.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Definition

1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Status and Outlook (2017-2031)

1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Comparison by Region (2017-2031)

1.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Comparison by Type (2017-2031)

1.5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Comparison by Application (2017-2031)

1.6 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Comparison by Sales Channel (2017-2031)

1.7 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Mergers/Acquisitions/Expansion)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

Chapter 2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Segment Analysis by Player

2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales and Market Share by Player (2020-2022)

2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Market Share by Player (2020-2022)

2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Price by Player (2020-2022)

2.4 Players Competition Situation & Trends

2.5 Conclusion of Segment by Player

Chapter 3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Segment Analysis by Type

3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Type

3.1.1 Lynparza

3.1.2 Zejula

3.1.3 Rubraca

3.1.4 Talzenna

3.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales and Market Share by Type (2017-2022)

3.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Market Share by Type (2017-2022)

3.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Price by Type (2017-2022)

3.5 Leading Players of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Type in 2022

3.6 Conclusion of Segment by Type

Chapter 4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Segment Analysis by Application

4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Application

4.1.1 Ovarian Cancer

4.1.2 Breast Cancer

4.1.3 Other

4.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Market Share by Application (2017-2022)

4.3 Leading Consumers of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Application in 2022

4.4 Conclusion of Segment by Application

Chapter 5 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Segment Analysis by Sales Channel

5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Sales Channel

5.1.1 Direct Channel

5.1.2 Distribution Channel

5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Market Share by Sales Channel (2017-2022)

5.3 Leading Distributors/Dealers of PARP (Poly ADP-Ribose Polymerase) Inhibitor by Sales Channel in 2022

5.4 Conclusion of Segment by Sales Channel

Chapter 6 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Segment Analysis by Region

6.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and CAGR by Region (2017-2031)

6.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales and Market Share by Region (2017-2022)

6.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Market Share by Region (2017-2022)

6.4 North America

6.4.1 North America Market by Country

6.4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type

6.4.3 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application

6.4.4 United States

6.4.5 Canada

6.4.6 Mexico

6.5 Europe

6.5.1 Europe Market by Country

6.5.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type

6.5.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application

6.5.4 Germany

6.5.5 UK

6.5.6 France

6.5.7 Italy

6.5.8 Russia

6.5.9 Spain

6.6 Asia-Pacific

6.6.1 Asia-Pacific Market by Country

6.6.2 Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type

6.6.3 Asia-Pacific PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application

6.6.4 China

6.6.5 Japan

6.6.6 Korea

6.6.7 India

6.6.8 Southeast Asia

6.6.9 Australia

6.7 South America

6.7.1 South America Market by Country

6.7.2 South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type

6.7.3 South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application

6.7.4 Brazil

6.7.5 Argentina

6.7.6 Colombia

6.8 Middle East & Africa

6.8.1 Middle East & Africa Market by Country

6.8.2 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type

6.8.3 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application

6.8.4 UAE

6.8.5 Saudi Arabia

6.8.6 South Africa

6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading PARP (Poly ADP-Ribose Polymerase) Inhibitor Players

7.1 AstraZeneca

7.1.1 Company Snapshot

7.1.2 Product/Service Offered

7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

7.2 Merck & Co

7.3 GSK

7.4 Clovis Oncology

7.5 Pfizer

7.6 Zai Lab

Chapter 8 Upstream and Downstream Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor

8.1 Industrial Chain of PARP (Poly ADP-Ribose Polymerase) Inhibitor

8.2 Upstream of PARP (Poly ADP-Ribose Polymerase) Inhibitor

8.3 Downstream of PARP (Poly ADP-Ribose Polymerase) Inhibitor

Chapter 9 Development Trend of PARP (Poly ADP-Ribose Polymerase) Inhibitor (2023-2031)

9.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (Sales and Revenue) Forecast (2023-2031)

9.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and CAGR Forecast by Region (2023-2031)

9.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and CAGR Forecast by Type (2023-2031)

9.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and CAGR Forecast by Application (2023-2031)

9.5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and CAGR Forecast by Sales Channel (2023-2031)

Chapter 10 Appendix

10.1 Research Methodology

10.2 Data Sources

10.3 Disclaimer

10.4 Analysts Certification

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
PARP (Poly ADP Ribose Polymerase) Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the PARP (Poly ADP Ribose Polymerase) Market trending toward high growth trajectories?
A dynamic process in the PARP (Poly ADP Ribose Polymerase) Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like AstraZeneca, Merck & Co, GSK, Clovis Oncology, Pfizer, Zai Lab.
Is the PARP (Poly ADP Ribose Polymerase) Market shifting its focus from growth to value?
Recognize the areas along the PARP (Poly ADP Ribose Polymerase) Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Where are the PARP (Poly ADP Ribose Polymerase) used?
The PARP (Poly ADP Ribose Polymerase) are employed in Ovarian Cancer, Breast Cancer, Other.
What is the size of the PARP (Poly ADP Ribose Polymerase) Industry?
According to the report, the PARP (Poly ADP Ribose Polymerase) Industry will grow to USD XXX Million by 2030, with a YY% CAGR.
What are the advantages of the PARP (Poly ADP Ribose Polymerase) Market research study?
The PARP (Poly ADP Ribose Polymerase) Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
What are the primary data sources used to evaluate the PARP (Poly ADP Ribose Polymerase) Market sizing?
The majority of data for the PARP (Poly ADP Ribose Polymerase) Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.